IL2 and type 1 diabetes mellitus: Furthermore, neutralizing anti-IL-2 antibodies have been found in pre-diabetic and diabetic NOD mice and T1D patients [44], and they are more likely to disrupt IL-2’s protective effect when administered at a lower dose.